Explain this page
Arphra AIPlain-English read on Zoetis Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
- ELVElevance Health Inc.$372.68$80.93B
- CICigna Corporation$282.90$74.59B
- REGNRegeneron Pharmaceuticals, Inc.$701.42$72.26B
- CORCencora, Inc.$304.00$59.14B
- BDXBecton, Dickinson and Company$149.31$54.09B
- TAKTakeda Pharmaceutical Company Limited$16.62$52.51B
- ARGXargenx SE$783.50$48.49B
- IDXXIDEXX Laboratories, Inc.$567.46$45.18B
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.51% | -2.70% | -33.09% | -39.34% | -37.68% | -39.29% | -55.14% | -55.36% | -56.05% | +59.38% | +146.34% |
Aftermarket
LiveLast trade
$76.89
2,441 sh
Bid
$76.27
25 sh
Ask
$78.22
64 sh
Spread
$1.950
Sector & industry today
LiveSectors
- Technology+1.59%
- Industrials+1.50%
- Energy+1.40%
- Basic Materials+1.36%
- Utilities+0.94%
- Consumer Cyclical+0.45%
- Real Estate+0.37%
- Consumer Defensive+0.28%
- Financial Services+0.05%
- Healthcare-0.26%
- Communication Services-0.39%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.07%
- Hardware, Equipment & Parts+5.17%
- Computer Hardware-4.64%
- REIT - Office+4.28%
- Communication Equipment+4.02%
- Electronic Gaming & Multimedia-3.94%
- Real Estate - Services+3.82%
- Agricultural - Machinery+3.64%
- Auto - Parts+3.58%
- Oil & Gas Energy+3.45%
- Information Technology Services+3.19%
- Copper+3.00%
Fair value
Football field →Weighted blend
$184.04
+140.92% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
10bull7bear
±5% threshold
Analyst PT consensus: $143.00 (+87.20%)
Total assets
$15.47B
Total debt
$9.49B
Cash & equiv
$2.31B
Operating CF
$2.9B
Free cash flow
$2.28B
Buybacks
-$3.24B
Analyst view
DB · price_targets + analyst_gradesConsensus target
$143.00
+87.20% upside
Low
$130.00
Median
$140.00
High
$160.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Zoetis (ZTS) Securities Fraud Investigation - Levi & Korsinskyprnewswire.com·May 13, 2026
- Zoetis (ZTS) Securities Fraud Investigation - Levi & Korsinskyprnewswire.com·May 13, 2026
- Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Zoetis Inc.prnewswire.com·May 07, 2026
- Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Zoetis Inc.prnewswire.com·May 07, 2026
- Zoetis Gears Up to Report Q1 Earnings: Is a Beat in the Cards?zacks.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $2.39B | $603M | $1.37 |
| Q3 Sep 2025 | $2.4B | $721M | $1.63 |
| Q2 Jun 2025 | $2.46B | $718M | $1.61 |
| Q1 Mar 2025 | $2.22B | $631M | $1.41 |
| Q4 Dec 2024 | $2.32B | $581M | $1.29 |
| Q3 Sep 2024 | $2.39B | $682M | $1.50 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
DAMELIO FRANK A director | Buy | 6,650 | $501.34K | May 13, 2026 |
Bisaro Paul director | Buy | 2,000 | $151.75K | May 13, 2026 |
MCCALLISTER MICHAEL B director | Buy | 3,000 | $233.27K | May 11, 2026 |
PECK KRISTIN C director, officer: Chief Executive Officer | Sell | 10,800 | $1.38M | Feb 17, 2026 |
PECK KRISTIN C director, officer: Chief Executive Officer | Sell | 9,200 | $1.16M | Feb 17, 2026 |
Lagano Roxanne officer: Executive Vice President | Sell | 652 | $110.84K | Jun 03, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $9.47B | $3.6B | $2.67B | $6.02 | +28.23% |
| FY 2024 | $9.26B | $3.39B | $2.49B | $5.47 | +26.86% |
| FY 2023 | $8.54B | $3.07B | $2.34B | $5.07 | +27.43% |
| FY 2022 | $8.08B | $2.93B | $2.11B | $4.49 | +26.16% |
| FY 2021 | $7.78B | $2.8B | $2.04B | $4.27 | +26.20% |